GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (OTCPK:GALDY) » Definitions » Inventories, Inventories Adjustments

GALDY (Galderma Group AG) Inventories, Inventories Adjustments : $0 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Inventories, Inventories Adjustments?

Galderma Group AG's Inventories, Inventories Adjustments for the quarter that ended in Jun. 2024 was $0 Mil.


Galderma Group AG Inventories, Inventories Adjustments Historical Data

The historical data trend for Galderma Group AG's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Inventories, Inventories Adjustments Chart

Galderma Group AG Annual Data
Trend
Inventories, Inventories Adjustments

Galderma Group AG Semi-Annual Data
Jun23 Jun24
Inventories, Inventories Adjustments - -

Galderma Group AG Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.


Galderma Group AG Business Description

Industry
Traded in Other Exchanges
Address
Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.